Neurological autoimmune disease and the trimolecular complex of T‐lymphocytes

Annals of Neurology

Volumn 25, Issue 6, 1989, Pages 531-538

  Hohlfeld, Reinhard ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; DIAGNOSIS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMAL; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NERVOUS SYSTEM DISEASES; RECEPTORS, ANTIGEN, T-CELL; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0024346608     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410250602     Document Type: Article

References (90)

1. Cellular immunity in neurologic diseases
2. Structure of the human class I histocompatibility antigen, HLA‐A2
3. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
4. The basis for the immunoregulatory role of macrophages and other accessory cells
5. Dendritic cells: features and functions
6. Cellular immune reactivity within the CNS
7. Immune‐mediated encephalitis: on the role of antigen‐presenting cells in brain tissue
8. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes
9. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules
10. T‐lymphocytes: ontogeny, function, and relevance to clinical disorders
11. The T cell receptor
12. i and T11 pathways
13. Cell surface molecules and early events involved in human T lymphocyte activation
14. The T cell receptor/CD3 complex: a dynamic protein ensemble
15. T cell CD3‐zeta‐eta heterodimer expression and coupling to phosphoinositide hydrolysis
16. Frontiers of the immune system
17. Binding of immunogenic peptides to Ia histocompatibility molecules
18. Antigenic competition at the level of peptide‐Ia binding
19. Isolation and characterization of antigen‐Ia complexes involved in T‐cell recognition
20. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides
21. Direct binding of influenza peptides to class I HLA molecules
22. Immunological self‐nonself discrimination
23. Antigen presentation pathways to class I and class II MHC‐restricted T‐lymphocytes
24. + T cell depletion in AIDS
25. The Ia molecule of the antigen‐presenting cell plays a critical role in immune response gene regulation of T cell activation
26. Identification of the T cell and Ia contact residues of a T cell antigenic epitope
27. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells
28. Immunodominance in T‐lymphocyte recognition
29. Prediction of Immunodominant helper T cell antigenic sites from the primary sequence
30. A sequence pattern common to T cell epitopes
31. Mammalian T‐lymphocye antigen receptor genes: Genetic and nongenetic potential to generate variability
32. Structure, organization and polymorphism of murine and human T‐cell receptor alpha‐ and beta‐chain gene families
33. T‐cell antigen receptor genes and T‐cell recognition
34. Myasthenia gravis and myasthenic syndromes
35. Myasthenia gravis
36. Thymic myogenesis, T‐lymphocytes, and the pathogenesis of myasthenia gravis
37. Genetic restriction of autoreactive acetylcholine receptor‐specific T‐lymphocytes in myasthenia gravis
38. Human T‐helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit
39. Analysis of helper‐T cell function by AChR‐reactive cell lines of defined AChR‐subunit specificity
40. T cell hybridomas reactive with the acetylcholine receptor and its subunits
41. Mapping the autosensitizing epitopes on acetylcholine receptors
42. Region of peptide 125–147 of AChR alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T‐cell immunity, and modulating autoantibodies
43. T‐cell epitopes in experimental autoimmune myasthenia gravis of the rat: Strain‐specific epitopes and cross‐reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica)
44. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis
45. T‐lymphocyte recognition of acetylcholine receptor: localization of the full T cell recognition profile on the extracellular part of the alpha chain of Torpedo californica acetylcholine receptor
46. Autoimmune T lymphocytes in myasthenia gravis: determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene
47. Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T‐lymphocytes in myasthenia gravis
48. A juxta‐membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis
49. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes
50. Proliferative response to acetylcholine receptor peptides in myasthenia gravis (Abstr)
51. HLA‐DQ‐beta chain polymorphism linked to myasthenia gravis
52. Direct evidence for functional self‐protein/Ia‐molecule complexes in vivo
53. Autologous peptides constitutively occupy the antigen binding site on Ia
54. A molecular basis for MHC class II‐associated autoimmunity
55. Experimental allergic encephalomyelitis: a useful model for multiple sclerosis
56. Demyelinating disease of the central and peripheral nervous systems: neuroimmunologic studies of patients and experimental animal disease models
57. Experimental allergic encephalomyelitis and experimental allergic neuritis
58. The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
59. Adoptive transfer of myelin‐basic protein‐sensitized T cells produces chronic relapsing demyelinating disease in mice
60. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection of lines and characterization of the T cells
61. T‐cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination
62. Immune response of Lewis rats to peptide C1 (residues 68–88) of guinea pig and rat myelin basic protein
63. Specificity of T lymphocyte lines for peptides of myelin basic protein
64. Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes
65. 1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant
66. Encephalitogenic activity of guinea pig myelin basic protein in the SJL/J mouse
67. T‐cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis
68. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice
69. Involvement of distinct murine T cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein
70. T cell specificity for class II (I‐A) and the encephalitogenic N‐terminal epitope of the autoantigen myelin basic protein
71. The autoreactive T cell population in experimental allergic encephalomyelitis: T cell receptor beta‐chain rearrangements
72. Peptide specificities of myelin‐basic protein‐reactive human T cell clones
73. Isolation of myelin‐basic protein‐reactive T cell lines from normal human blood
74. + cytolytic T‐lymphocyte clones isolated from multiple sclerosis patients
75. Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen‐presenting cells influences immunodominant epitope of basic protein
76. 1 mice
77. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
78. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy
79. Oligoclonal T‐lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis
80. Analysis of T cell receptor gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis
81. Toward a network theory of the immune system
82. Anti‐idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis
83. Suppression of experimentally induced encephalomyelitis by cytolytic T‐T cell interactions
84. The self, the world, and autoimmunity
85. Strategies for the modulation of neuroimmunological disease at the level of autoreactive T‐lymphocytes
86. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
87. In vivo competition between self peptides and foreign antigens in T‐cell activation
88. A speculative view of the multicomponent nature of T cell antigen recognition
89. The lymphocyte function‐associated LFA‐1, CD2, and LFA‐3 molecules: cell adhesion receptors of the immune system